Veraxa Biotech AG - Post de-SPAC VRXA
NASDAQ VRXA
$1.13 -0.06 (-5.04%)
At close: Oct 2, 2026 · 4:00 PM EDT

Veraxa Biotech AG - Post de-SPAC (VRXA) Cash & Equivalents (2024 - 2025)

Updated

Veraxa Biotech AG - Post de-SPAC (VRXA) posted Cash & Equivalents of $2.02 million for the quarter ended Dec 31, 2025, down 67.0% from $6.12 million a year earlier.

Analysis

Veraxa Biotech AG - Post de-SPAC (VRXA) Cash & Equivalents (2024 - 2025) Analysis & Trends

As of Dec 31, 2025, Veraxa Biotech AG - Post de-SPAC's Cash & Equivalents came in at $1.95 million, down 68.1% from the prior year.

  • In prior years, Veraxa Biotech AG - Post de-SPAC's Cash & Equivalents was $6.1 million in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.42 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.85 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.89 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 976.00 Mn
10 Veraxa Biotech AG - Post de-SPAC 16.36 Mn 12.95 Mn - 2.02 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 2.02 Mn
Dec 31, 2024 6.12 Mn
API Access

Veraxa Biotech AG - Post de-SPAC Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=VRXA&period=max&api_key=YOUR_API_KEY